ImmunityBio, Inc.
Public
IBRX
SectorHealthcare
CountryUnited States
Market cap8.31B
ImmunityBio, Inc.,A clinical-stage immunotherapy company developing advanced cell and gene therapies designed to strengthen the immune system against cancer and infectious diseases.
